FORTIS HEALTHCARE LTD. - 532843 - Closure of Trading Window
With reference to the provisions of Policy / Code of Conduct for Prevention of Insider Trading, the "Trading Window" for dealing in shares of the Company is closed from September 30, 2022 till 48 hours from declaration of financial results for the quarter and period ending on September 30, 2022.
IHH Healthcare in discussions with Indian authorities over stalled open offer in Fortis Healthcare
The Supreme Court had last week ordered a forensic audit of the share sale of Fortis Healthcare to IHH Healthcare executed in 2018, in a contempt case filed by Japanese firm Daiichi Sankyo Company Ltd against the former promoters of Fortis, Singh brothers -- Malvinder and Shivinder, and others.
Fortis Healthcare ex-promoters failed to purge themselves of contempt: SC
The Supreme Court has held the former promoters of Fortis Healthcare Ltd Malvinder Singh and Shivinder Singh have failed to purge themselves of contempt by not making a genuine attempt to pay Rs 1170.95 crore each towards honouring an arbitral award against them, and handed down six months jail term to them. The contempt proceedings arose out of an action initiated by Japanese firm Daiichi Sankyo Company Limited, seeking enforcement of a foreign arbitral award made in Singapore on April 29, 2016 to the tune of Rs 3,600 crore in its favour and against 20 respondents including Malvinder Mohan Singh, Director of Oscar Investments Limited and RHC Holding Private Limited and Shivinder Mohan Singh, Director of Oscar Investments Limited. The former promoters of Fortis Healthcare Ltd were facing a court battle after Daiichi had challenged the Fortis-IHH share deal to recover the Rs 3,600 crore arbitration award. The IHH-Fortis deal is stuck due to the legal fight between Daiichi and the... FORTIS HEALTHCARE LTD. - 532843 - Intimation Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
This is in continuation of earlier intimations namely: FHL/SEC/2018-19 dated December 15, 2018; FHL/SEC/2018-19 dated December 17, 2018 in matter of Vinay Prakash Singh v. Sameer Gehlaut & Ors.; FHL/SEC/2019-20 dated November 18, 2019 on Suo Moto Contempt Petition No. 04 of 2019 ('Suo Moto Contempt Petition'); FHL/SEC/2019-20 dated March 5, 2020; FHL/SEC/2020-21 dated August 14, 2020; and further announcement ref. no. FHL/SEC/2022-23 dated September 22, 2022 regarding judgement of Hon'ble Supreme Court in respect of Suo Moto Contempt Petition. The Hon'ble Supreme Court of India pronounced final judgment in respect of Suo Moto Contempt Petition and connected proceedings, (i.e., Special Leave Petition (Civil) No. 20417 of 2017 and Contempt Petition No.2120 of 2018 in SLP (C) No.20417 of 2019) on September 22, 2022. The written judgment was made available earlier today (September 23, 2022) ('Judgment'). The key observations made in Judgement inter-alia covering disclosures are enclosed.
Fortis-IHH healthcare case: Why is the trouble and what next?
Despite Fortis being well positioned in terms of finances, health industry analysts hold that thecompany's near future plans,which havealready suffered delays due to Covid,might have to be put on hold. Old ghosts continue to haunt the IHH-Fortis transaction
Experts concerned on the impact it would have on investment in healthcare FORTIS HEALTHCARE LTD. - 532843 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
This is in continuation of our earlier intimations ref. no. FHL/SEC/2018-19 dated December 15, 2018, FHL/SEC/2018-19 dated December 17, 2018 in the matter of Vinay Prakash Singh v. Sameer Gehlaut & Ors. directing ''Status quo with regard to sale of the controlling stake in Fortis Healthcare to Malaysian IHH Healthcare Berhad be maintained'' and FHL/SEC/2019-20 dated November 18, 2019 on the Suo Moto Contempt Petition No. 04 of 2019. In this regard we would like to inform that the proceedings before the Hon'ble Supreme Court have concluded with certain directions and the suo-motu contempt has been disposed-off. We are seeking legal advice to decide our future course of action. We remain committed to our core purpose of patient care and will continue to focus on our strategic and operational objectives to further strengthen and expand our healthcare network. We will keep all our stakeholders informed, as required. This is for your information and records please. FORTIS HEALTHCARE LTD. - 532843 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Fortis Healthcare Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here FORTIS HEALTHCARE LTD. - 532843 - Proceedings And Voting Result Under SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
With reference to the Postal Ballot Notice dated August 5, 2022, following resolutions have been approved with requisite majority through e-voting: - - Amalgamation of Fortis Asia Healthcare Pte Limited ('FAHPL') and Fortis Healthcare International Pte Limited ('FHIPL'), step-down subsidiaries of the Company, including conversion of outstanding intercorporate loan into redeemable preference shares and amendment in terms of the existing redeemable preference shares of FAHPL - Special Resolution. - Acquisition of Land and Building adjacent to Fortis Hospital, Anandpur, Kolkata by way of transfer of license to International Hospital Limited, a subsidiary of the Company from Artistery Properties Private Limited - Special Resolution. Please find enclosed Scrutinizer's Report along with result of postal ballot in prescribed format. FORTIS HEALTHCARE LTD. - 532843 - Clarification W.R.T. Increase In Volume Of Shares.
This is in reference to your email dated September 15, 2022 having reference no. L/SURV/ONL/PV/SR/2022-2023/197, we would like to clarify that the Company has been regularly sharing all information / announcements that may be having any bearing on the operation/ performance of the Company including all price sensitive information with the stock exchange. The increase in the volume of the security across the exchanges, in the recent past, appears to be due to market conditions / market driven. The Company reiterates its adherence to the requirements laid down in regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and we will keep the stock exchanges duly informed of any information as may be required under the said regulations as and when any such event occurs. This is for your information and record.